MindfulGarden Digital Health Inc.

MindfulGarden (MG) is addressing the high human and economic costs associated with in-hospital delirium, a sudden change in the brain that results in longer stays, increased mortality, and a 9X chance of future cognitive impairment including earlier onset of dementia. The company’s patent pending interactive biofeedback platform distracts, engages and de-escalates patient agitation levels, leading to a reduction in the use of antipsychotic drugs, and 1:1 nursing time, resulting in significant health system cost savings, and better overall patient outcomes.